Cision PR Newswire

AccidentAccidentAir PollutionAll NewsAnnoucementArgricultureArtASEANBook

Vimi Wellness Founder Zhang Xinyuan Hosts “6V of Happiness: Life Is a Stage,” Celebrating Women’s Growth Through Performance

HENGDIAN, China, Nov. 5, 2026 /PRNewswire/ -- Zhang Xinyuan, founder of Vimi Wellness and a relationship expert, hosted "6V of Happiness: Life Is a Stage," a five-day theatrical competition held from October 27 to 31, 2026, bringing together women from across China for professional training and stage performances. Winners earned...

Minesto’s tidal energy project recognised under EU STEP initiative supporting European industrial competitiveness

GOTHENBURG, Sweden, Nov. 5, 2026 /PRNewswire/ -- Minesto, leading ocean energy developer, has received...
Cision PR Newswire

Tencent Showcases Global Payment Connectivity and AI-Powered Finance at Hong Kong FinTech Week 2026

HONG KONG, Nov. 5, 2026 /PRNewswire/ -- Tencent joined Hong Kong FinTech Week x...
Cision PR Newswire

/D I S R E G A R D – Centelon/

Cision PR Newswire

Finshape launches Agentic DBOS: agentic AI already supporting digital banking projects

PRAGUE, Nov. 5, 2026 /PRNewswire/ -- Finshape has launched Agentic DBOS (ADBOS), adding agentic AI to...
Cision PR Newswire

Smartpay Announces Japan’s First “Embedded Insurance Service” in BNPL in Partnership with Chubb

~ Launching New Insurance Experience Integrating Payments and Insurance in Summer 2025 TOKYO, March 6, 2025 /PRNewswire/ -- Smartpay Corporation (Headquarters: Minato-ku, Tokyo;...

Transforming Sales: 6D Technologies Empowers Filipino Mobile Services Provider Smart

BARCELONA,...

Wahed, an Islamic robo-advisor, appoints Shahril Hamdan to its Board of Directors

KUALA LUMPUR, Malaysia, March 6, 2025 /PRNewswire/ -- Wahed, a global Shariah-compliant fintech has appointed Shahril Hamdan to its Board of Directors. ...

Movement Labs Announces “GMove: Move Asia’s Future” APAC Tour Following Mainnet Launch

SAN...

HKA WELCOMES ADAM SMITH AS A PRINCIPAL IN THE ADVISORY TEAM IN AUSTRALIA

SYDNEY,...

Akeso Announces Completion of Patient Enrollment in The Phase III Clinical Trial of Cadonilimab for Adjuvant Treatment of High-Risk Recurrent Hepatocellular Carcinoma

HONG KONG, March 6, 2025 /PRNewswire/ -- Akeso, Inc. (9926. HK) ("Akeso" or the "Company") is pleased to announce the completion of patient enrollment...
1...4,0284,0294,030...4,505Page 4,029 of 4,505